874493-25-1 Usage
Uses
Used in Pharmaceutical Industry:
3-BROMO-2-HYDROXY-5-NITRO-6-PICOLINE is used as an intermediate in the synthesis of pharmaceuticals for its reactivity and ability to form complex organic molecules, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 3-BROMO-2-HYDROXY-5-NITRO-6-PICOLINE is utilized as a precursor in the production of agrochemicals, aiding in the creation of effective pesticides and other agricultural chemicals to protect crops and enhance yields.
Used in Fine Chemicals Industry:
3-BROMO-2-HYDROXY-5-NITRO-6-PICOLINE is employed as a building block in the synthesis of fine chemicals, which are high-purity chemicals used in various applications such as research, diagnostics, and specialty manufacturing.
Used in Dye and Pigment Manufacturing:
3-BROMO-2-HYDROXY-5-NITRO-6-PICOLINE is used in the production of dyes and pigments due to its potential to form colored organic compounds, which are essential in various industries such as textiles, plastics, and printing inks.
It is crucial to handle 3-BROMO-2-HYDROXY-5-NITRO-6-PICOLINE with care due to its reactivity and potential hazards, ensuring safe practices in laboratories and manufacturing facilities.
Check Digit Verification of cas no
The CAS Registry Mumber 874493-25-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,4,4,9 and 3 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 874493-25:
(8*8)+(7*7)+(6*4)+(5*4)+(4*9)+(3*3)+(2*2)+(1*5)=211
211 % 10 = 1
So 874493-25-1 is a valid CAS Registry Number.
874493-25-1Relevant academic research and scientific papers
PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS
-
Paragraph 1923; 1924, (2018/07/05)
Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, R5, R6, R5, G1, and G2 are defined herein.
EZH2 Inhibitors
-
Paragraph 0270; 0274; 0275, (2018/11/02)
The present invention relates to compounds that inhibit EZH2 activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1
-
Paragraph 00257-00258, (2016/05/02)
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compou
INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1
-
Paragraph 0273; 0274, (2015/06/25)
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compou
NOVEL MICROBIOCIDES
-
Page/Page column 42, (2008/12/08)
Compounds of the formula (I) in which the substituents are as defined in claim 1 are suitable for use as microbiocides.
